Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Red raspberry leaf extract is a botanical dietary supplement being investigated for its potential role in weight management. Its proposed mechanism of action involves the inhibition of two key enzymes: Diacylglycerol acyltransferase-1 (DGAT-1) and ghrelin O-acyltransferase (GOAT). Inhibition of DGAT-1 is hypothesized to reduce the re-esterification of dietary fats into circulating triglycerides, potentially leading to decreased fat deposition. Inhibition of GOAT aims to prevent the activation of ghrelin, a hormone that stimulates appetite, thereby potentially diminishing food intake and lipid storage. This extract is being studied for its effects on appetite and fat metabolism in healthy, overweight, and obese individuals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on red raspberry leaf extract.